Market Momentum Report: Neogenomics Inc (NEO)’s Negative Close at 9.09

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

The price of Neogenomics Inc (NASDAQ: NEO) closed at $9.09 in the last session, down -10.05% from day before closing price of $10.10. In other words, the price has decreased by -$10.05 from its previous closing price. On the day, 1.65 million shares were traded.

Ratios:

We take a closer look at NEO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.89 and its Current Ratio is at 1.98. In the meantime, Its Debt-to-Equity ratio is 0.67 whereas as Long-Term Debt/Eq ratio is at 0.44.

On December 10, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $22.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 15 ’24 when Olivo Alicia C sold 5,175 shares for $15.36 per share. The transaction valued at 79,475 led to the insider holds 37,129 shares of the business.

ALICIA OLIVO bought 5,175 shares of NEO for $81,713 on Nov 15 ’24. On Aug 15 ’24, another insider, Olivo Alicia C, who serves as the General Counsel of the company, sold 1,040 shares for $16.05 each. As a result, the insider received 16,695 and left with 43,813 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 1.77 while its Price-to-Book (P/B) ratio in mrq is 1.29.

Stock Price History:

Over the past 52 weeks, NEO has reached a high of $19.11, while it has fallen to a 52-week low of $8.98. The 50-Day Moving Average of the stock is -33.79%, while the 200-Day Moving Average is calculated to be -38.66%.

Shares Statistics:

A total of 128.15M shares are outstanding, with a floating share count of 126.92M. Insiders hold about 1.20% of the company’s shares, while institutions hold 97.21% stake in the company.

Most Popular